The detailed review focuses on engineered Interleukin-3 (IL-3), a significant factor participating in blood cell formation and immunological responses . This covers its composition and mechanism of action , encompassing data from laboratory trials and clinical uses . Furthermore , the section examines current medicinal promise and drawbacks linked